What We Gained that Time We Lost so Much: Demographic Trends and Territorial Control in Mexico After the War with the United States
European Review of Economic History · 10.11.2026 · 30 (4) · 721-745
DOI: 10.1093/ereh/heag019 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Review of Economic History, online erschienen am 15.06.2026. Verfasst von Diego Castañeda Garza und 1 weiteren Autor:innen. Die Arbeit nennt 57 Literaturangaben. Gefördert von: Jan Wallanders och Tom Hedelius stiftelse.
Abstract (Originalsprache)
This paper examines the role of demographic dynamics in shaping Mexico’s evolution between the American invasion (1846–1848) and the French intervention. It shifts focus from state capacity to population trends, revealing how a sparsely populated frontier transformed into a strategically controlled border. This demographic shift strengthened territorial control and state resilience, laying the groundwork for a more robust state. The study provides new insights into Mexico’s historical development through the lens of demographic change during this critical period.
Förderung
- Jan Wallanders och Tom Hedelius stiftelse
Zitieren
APA
Garza, D. C., & Castañeda, S. S. (2026). What We Gained that Time We Lost so Much: Demographic Trends and Territorial Control in Mexico After the War with the United States. European Review of Economic History, 30(4), 721-745. https://doi.org/10.1093/ereh/heag019
Vancouver
Garza DC, Castañeda SS. What We Gained that Time We Lost so Much: Demographic Trends and Territorial Control in Mexico After the War with the United States. European Review of Economic History. 2026;30(4):721-745. doi:10.1093/ereh/heag019
BibTeX
@article{Garza2026,
author = {Garza, Diego Castañeda and Castañeda, Sergio Silva},
title = {What We Gained that Time We Lost so Much: Demographic Trends and Territorial Control in Mexico After the War with the United States},
journal = {European Review of Economic History},
year = {2026},
volume = {30},
number = {4},
pages = {721--745},
doi = {10.1093/ereh/heag019}
}
EUVIMED